Trial intelligence / Profile preview

High-Dose vs Standard IV Magnesium Sulfate for Status Asthmaticus in the ED

NCT07795970Not yet recruiting

Sponsor
Thammasat University
Start
Nov 2026
Primary completion
Nov 2027
01

Overview

Randomised trial of magnesium sulfate in asthma (2 arms), sponsored by Thammasat University. Primary endpoints: Length of Emergency Department stay and Emergency Department revisit within 48 hours post-discharge. Planned start Nov 2026; status: not yet recruiting.

02

Drugs

magnesium sulfate
03

Conditions

asthma

Beyond the preview

Go deeper on NCT07795970.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07795970.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call